Survivor Story
Irasema Chavez shares her inspiring story about overcoming stomach cancer and breast cancer in the AACR Cancer Disparities Progress Report.
Irasema's Story and Video
Irasema Chavez shares her inspiring story about overcoming stomach cancer and breast cancer in the AACR Cancer Disparities Progress Report.
Irasema's Story and VideoCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreDisparities in the Burden of Preventable Cancer Risk Factors: Long-standing inequities in numerous social drivers of health contribute to significant disparities in the burden of preventable cancer risk factors.
Read the ReportMore than 41,500 people a year in the U.S. are diagnosed with liver cancer. Read about the prevention, screening, and treatment options for this type of cancer.
Learn MoreA postdoctoral fellowship grant from the AACR helped propel Dr. Marco Ruella’s research to improve immunotherapy for patients whose disease evaded prior treatment or relapsed.
Learn MoreRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreYour donation to the American Association for Cancer Research will help fund early-career investigators. Fund the future of cancer research today.
Donate NowAdvance registration is open for the AACR Annual Meeting 2025. Register by Friday, March 7, to receive discounted rates.
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
